|
|
||||||||
1 Dept of Internal Medicine, Division of Respiratory and Infectious Diseases, St. Marianna School of Medicine, Kawasaki, 2 Second Dept of Internal Medicine, Toho University School of Medicine, Tokyo, Japan
CORRESPONDENCE: M. Hoshino, Division of Respiratory and Infectious Diseases, Dept of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Japan. Fax: 81 449778361. E-mail: mhoshino@marianna-u.ac.jp
Keywords: airway remodelling, airway vascularity, angiogenesis, stromal-cell derived factor-1
Received: September 3, 2002
Accepted January 2, 2003
Stromal cell-derived factor-1 (SDF-1) acts as a chemoattractant for leukocytes and can induce neovascularisation. To examine the role of SDF-1 in the development of angiogenesis, immunohistochemical studies were performed on bronchial biopsy specimens from asthmatic and control subjects.
Bronchial biopsy specimens were obtained from 13 asthmatic and eight control subjects. The number of vessels and the percentage area they occupied were estimated after staining for type-IV collagen. In addition the number of SDF-1-positive cells was determined.
There was a significant increase in the number of vessels and the percentage vascularity in the submucosa of asthmatic subjects compared with control subjects. Asthmatic subjects exhibited a greater number of SDF-1-positive cells in the airway mucosa than control subjects. The degree of vascularity was associated with the number of SDF-1-positive cells. Furthermore, the number of SDF-1-positive cells was inversely correlated with airway calibre and airway hyperresponsiveness. Colocalisation studies revealed that endothelial cells, macrophages and T-lymphocytes were the major sources of SDF-1.
These findings suggest that increased vascularity of bronchial mucosa in asthmatic subjects is closely related to the expression of stromal cell-derived factor-1 positive cells, which may play a role in remodelling of airways via angiogenesis.
This article has been cited by other articles:
![]() |
C.-H. Wang, C.-D. Huang, H.-C. Lin, K.-Y. Lee, S.-M. Lin, C.-Y. Liu, K.-H. Huang, Y.-S. Ko, K. F. Chung, and H.-P. Kuo Increased Circulating Fibrocytes in Asthma with Chronic Airflow Obstruction Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 583 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horvath and A. Wanner Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur. Respir. J., January 1, 2006; 27(1): 172 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Burgess, Q. Ge, M. H. Poniris, S. Boustany, S. M. Twigg, J. L. Black, and P. R. A. Johnson Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L153 - L161. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, et al. CXCL12 and Vascular Endothelial Growth Factor Synergistically Induce Neoangiogenesis in Human Ovarian Cancers Cancer Res., January 15, 2005; 65(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |